BiotechTube
Home/Alterome Therapeutics/Scott Moorefield
SM

Scott Moorefield

COO & CBO

Alterome Therapeutics

Therapeutic Areas

Oncology

Alterome Therapeutics Pipeline

DrugIndicationPhase
ALTA-2618AKT E17K-driven cancersPhase 1
ALTA-3263KRAS-driven cancersPhase 1

Leadership Team at Alterome Therapeutics

JC
Jung Choi
CEO
L(
Leonardo (Leo) Faoro
CMO
MB
Michael Bartberger
Executive VP, Discovery Research
RC
Ryan Corcoran
Co-founder, SAB Chair
View full Alterome Therapeutics profile